Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease

Inclusion Criteria:

• Have a diagnosis of probable Alzheimer's disease;

• Have an MMSE score between 10 and 20;

• Must be able to swallow capsule/tablet;

• Must have a caregiver who is able to attend all study visits;

Exclusion Criteria:

• Have an advanced, severe, progressive, or unstable disease of any type that mayinterfere with efficacy and safety assessments or put the patient at special risk;

• Have a current diagnosis of active, uncontrolled seizure disorder;

• Have a history within the past year or current diagnosis of cerebrovascular disease

• Have a current diagnosis of severe or unstable cardiovascular disease;

• Had a myocardial infarction (MI) within the last six months;

• Have specific respiratory, digestive, renal, or endocrine disorders;

• Have had previous treatment with rivastigmine or memantine; Other protocol-defined inclusion/exclusion criteria may apply